Renal Denervation for Hypertension: From Innovation to Indication

Area of Science:

• Cardiology
• Nephrology
• Public Health

Background:

• Hypertension remains a significant global health challenge, with a substantial portion of adults exhibiting uncontrolled blood pressure despite established treatments.
• Treatment nonadherence is a key barrier to achieving blood pressure control, necessitating novel therapeutic strategies.
• Established interventions like medication and lifestyle modifications have limitations in widespread efficacy.

Discussion:

• This special issue introduces advancements in hypertension management, focusing on device-based therapies and novel agents like silencing ribonucleic acids.
• These newer approaches demonstrate high efficacy and circumvent adherence issues due to their administration within healthcare settings.
• The historical context and current epidemiology of hypertension underscore the public health imperative for improved blood pressure management.

Key Insights:

• Emerging therapies, including renal denervation, offer high efficacy in lowering blood pressure.
• In-office administration of new treatments enhances patient adherence compared to traditional methods.
• Optimizing blood pressure control is crucial for preventing target organ damage associated with hypertension.

Outlook:

• Future research will explore patient selection criteria for renal denervation.
• Efficacy, success measurement, and procedural guidance for renal denervation will be detailed.
• Renal denervation represents a promising emerging therapy for managing resistant hypertension.